Deals
Search SEC
Investors
Sectors
Insights
Ask AI
Signal
Pricing
API
Sign In
Get Access
Deals
Search SEC
Investors
Sectors
Insights
Ask AI
Signal
Pricing
API
Sign In
Get Access
← All investors
Schroder Ventures Life Sciences Advisers
1 portfolio company · $2.1M tracked · Public Equity (NASDAQ)
Portfolio companies
NEUROCRINE BIOSCIENCES, INC.
Rule 144
Public Equity (NASDAQ)
· San Diego, CA
$2.1M
Signal 64
Other investors
JPMorgan Chase & Co
Bessemer Venture Partners
Kleiner Perkins
Andreessen Horowitz